Clinical Trials

Title   SWOG 1505
Principal Investigator/ Physician   Marcus Tan, MD
Protocol┬áNo.   S1505
Open Date   05/18/2016
Gender   Both
Cancer Site   Pancreatic
Status   Open
Sponsor   SWOG
Contact Email   MCI Clinical Trials
Summary  

Protocol Title:  "A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma."

Inclusion Criteria: Patient must have measurable disease in the pancreas, patients must have resectable primary tumor based on contract-enhanced CT or MRI of the chest, abdomen, and pelvis; patient must not have received prior surgery, radiation therapy, chemotherapy, targeted therapy or any investigational therapy for pancreatic cancer, must have Zubrod performance status of 0-1.

Clinical Trails.Gov Link  https://clinicaltrials.gov/ct2/show/NCT02562716?term=s1505&rank=1

Email Newsletters

Connect With Us